Yahoo
    OTC Markets OTCQB - Delayed Quote USD

    Protagenic Therapeutics, Inc. (PTIX)

    0.6380 -0.0080 (-1.24%)
    At close: October 30 at 4:00:00 PM EDT
    Loading Chart for PTIX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
    ACCESS Newswire 6mo ago

    Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner
    ACCESS Newswire 5mo ago
    Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder

    Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder
    ACCESS Newswire 2mo ago

    Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
    ACCESS Newswire 4mo ago

    Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
    ACCESS Newswire 7mo ago

    Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
    ACCESS Newswire 7mo ago

    Results from Phase 1 Multiple-Dose Study of PT00114
    ACCESS Newswire 10mo ago
    Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice

    Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
    ACCESS Newswire 10mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: